284 J . Org. Chem., Vol. 67, No. 1, 2002
Notes
removed under reduced pressure. The residual oil was dissolved
in EtOAc and washed consecutively with NaHCO3 (×3), 5% citric
acid (×3), H2O (×2), and brine (×1). After drying over anhydrous
Na2SO4 and filtration, the desired ester 3 (890 mg, 95%) was
purified by silica gel column chromatography eluted with
hexane/EtOAc (80/20). Rf ) 0.35 (hexane/EtOAc ) 65/35). 1H
NMR (400 MHz, CDCl3): δ 5.80 (d, J ) 1.9 Hz, 1 H), 4.64 (dd,
J ) 11.1, 4.1 Hz, 1 H), 2.48-2.28 (m, 3 H), 2.22 (m, 1 H), 2.07
(s, 3 H), 1.98-1.62 (m, 5 H), 1.49 (m, 1 H), 1.26 (s, 3 H). 13C
NMR (100 MHz, CDCl3): δ_198.9, 170.3, 166.7, 125.8, 79.2, 40.4,
34.0, 33.5, 31.8, 26.9, 22.9, 21.1, 16.6. IR (neat): 2959, 2873,
1732, 1679, 1626, 1461, 1169, 1090,1003, 864 cm-1. HRMS: calcd
for C13H19O3 (M + 1)+ 223.1334, found 223.1332.
Gen er a l P r oced u r e for th e P r ep a r a tion of Ra cem ic
Ester s 4-6. The procedure is similar to that for acetate 3, except
suitable acyl chlorides (butanoyl, hexanoyl, and octanoyl) instead
of anhydrides were used as the acylating agents. The desired
esters 4-6 were purified by silica gel column chromatography
eluted with hexane/EtOAc (8/2 f 6/4).
Bu ta n oic Acid (1S*,8a S*)-(()-8a -Meth yl-6-oxo-1,2,3,4,6,7,
8,8a -octa h yd r on a p h th a len -1-yl Ester (4). Yield: 98%. Mp:
43-44 °C. Rf ) 0.47 (hexane/EtOAc ) 65/35). 1H NMR (400
MHz, CDCl3): δ 5.77 (d, J ) 1.9 Hz, 1 H), 4.62 (dd, J ) 12.0, 4.1
Hz, 1 H), 2.45-2.14 (m, 6 H), 1.98-1.58 (m, 7 H), 1.46 (m, 1 H),
1.24 (s, 3 H), 0.93 (t, J ) 7.3 Hz, 3 H). 13C NMR (100 MHz,
CDCl3): δ 198.9, 172.9, 166.8, 125.8, 78.9, 40.4, 36.5, 34.0, 33.5,
31.8, 26.9, 22.9, 18.6, 16.7, 13.7. IR (neat): 2952, 1737, 1673,
1241, 1038 cm-1. HRMS: calcd for C15H23O3 (M + 1)+ 251.1647,
found 223.1644. Optically enriched (1S,8aS)-4 was similarly
prepared from (4S,5aS)-enriched 2.
the availability of (1S,8aS)-enriched ester 4 to develop a
practical method for the large-scale preparation of enan-
tiomerically pure (4aS,5S)-2. For a gram-scale operation,
the condition for the resolution was the same as the one
depicted in Scheme 2, except (1S,8aS)-enriched butanoate
4 (58% ee) instead of the racemate was used as the
substrate. Optically enriched (S)-13,6 (Scheme 1) was first
reduced to hydroxyenone 2, which was subjected to
acylation with butanoyl chloride to offer (1S,8aS)-
enriched butanoate 4 (58% ee). After enzymatic hydroly-
sis, both (4aS,5S)-2 and the remaining ester were ex-
tracted from the mixture with EtOAc. These two com-
pounds could easily be separated by partitioning in
n-hexane/H2O. The remaining ester goes to the hexane
layer, while (4aS,5S)-2 stays in the aqueous phase. This
simple extraction/partition procedure is especially con-
venient and suitable for a large-scale operation. It avoids
the need of extensive chromatography for the separation
of (4aS,5S)-2 from the remaining ester. Hydroxyenone
(4aS,5S)-2 of high optical purity (>97% ee) could thus
be obtained in 57% yield.
In conclusion, we have developed a convenient chemo-
enzymatic method for the preparation of (4aS,5S)-4,-
4a,5,6,7,8-hexahydro-5-hydroxy-4a-methylnaphthalen-
2(3H)-one (2) by taking advantage of the excellent
enantioselectivity of alcalase. Butanoate 4 was found to
be the best substrate, and it gave a product with the
predicted absolute stereochemistry. The carboxylate moi-
ety of butanoate 4 not only plays an important role in
the rate of alcalase-catalyzed hydrolysis, it also offers the
advantage of simplifying the purification procedure after
enzymatic resolution. Although only alcalase was studied
in this report, its low cost and readily availability would
make this procedure very useful in a gram-scale opera-
tion for securing (4aS,5S)-(+)-2 in high optical purity. We
are currently surveying other hydrolytic enzymes, includ-
ing esterases and lipases, for the hydrolysis of the
butanoate 4. It is interesting to note that lipases might
display a reverse enantiopreference for this substrate,
based on the knowledge of the binding pocket of lipases.12b
A recent example of lipase-catalyzed transesterification
on a structurally similar secondary alcohol also supports
this prediction.16 We will report the results in due course.
Hexa n oic Acid (1S*,8a S*)-(()-8a -Meth yl-6-oxo-1,2,3,4,6,7,
8,8a -octa h yd r on a p h th a len -1-yl Ester (5). Yield: 90%. Rf )
0.52 (hexane/EtOAc ) 65/35). 1H NMR (400 MHz, CDCl3): δ
5.76 (d, J ) 1.9 Hz, 1 H), 4.61 (dd, J ) 11.7, 4.1 Hz, 1 H), 2.43-
2.18 (m, 6 H), 1.98-1.55 (m, 7 H), 1.46 (m, 1 H), 1.32-1.27 (m,
4 H), 1.23 (s, 3 H), 0.86 (t, J ) 7 Hz, 3 H). 13C NMR (100 MHz,
CDCl3): δ 198.9, 173.1, 166.8, 125.8, 78.9, 40.4, 34.5, 34.0, 33.5,
31.8, 31.2, 26.9, 24.7, 22.9, 22.3, 16.7, 13.9. IR (neat): 2957, 2864,
1738, 1682, 1240, 1170, 1006, 774 cm-1. HRMS: calcd for
C
17H27O3 (M + 1)+ 279.1960, found 279.1964.
Octa n oic Acid (1S*,8a S*)-(()-8a -Meth yl-6-oxo-1,2,3,4,6,7,
8,8a -octa h yd r on a p h th a len -1-yl Ester (6). Yield: 90%. Rf )
0.60 (hexane/EtOAc ) 65/35). 1H NMR (400 MHz, CDCl3): δ
5.76 (d, J ) 1.8 Hz, 1 H), 4.61 (dd, J ) 12.7, 4.1 Hz, 1 H), 2.37-
2.22 (m, 6 H), 1.98-1.58 (m, 7 H), 1.57-1.36 (m, 1 H), 1.32-
1.27 (m, 11 H), 0.85-0.82 (m, 3 H). 13C NMR (100 MHz,
CDCl3): δ 198.8, 172.9, 166.7, 125.6, 78.7, 40.3, 34.4, 33.8, 33.3,
31.6, 31.5, 28.9, 28.7, 26.7, 24.9, 22.8, 22.4, 16.5, 13.9. IR
(neat): 2934, 2863, 1738, 1684, 1469, 1452, 1166, 1006 cm-1
.
HRMS: calcd for C19H31O3 (M + 1)+ 307.2273, found 307.2271.
Alca la se-Ca ta lyzed Hyd r olysis of Ra cem ic Ester s 3-6
(An a lytica l Sca le). Two stock solutions were first prepared;
solution A contains 0.333 M of individual substrate in DMF and
solution B contains 25% Alcalase 2.4L9 (v/v) in 0.3 M phosphate
buffer (pH 7.0). For each reaction, 60 µL of solution A and 300
µL of phosphate buffer (0.3 M, pH 7.0) were first mixed. A 40
µL portion of solution B (total volume ) 400 µL) was then added
and the mixture placed in a shaker at 37 °C. The reactions were
terminated at 6, 12, 24, and 48 h, respectively, by addition of
EtOAc (20 mL) and H2O (10 mL). The organic layer was collected
and washed with H2O (10 mL ×2) and brine (10 mL ×1). It was
dried over anhydrous Na2SO4, filtered, and concentrated to
dryness. The residue was dissolved in n-hexance/i-PrOH for
HPLC analysis.
Exp er im en ta l Section :
Gen er a l Meth od s. Melting points are uncorrected. 1H and
13C NMR spectra were recorded at 400 and 100 MHz in CDCl3,
respectively. Analytical TLC (silica gel, 60F-54, Merck) and spots
were visualized under UV light and/or phosphomolybdic acid-
ethanol. Flash column chromatography was performed with
silica gel 60 (70-230 mesh, Merck). HPLC was performed on a
Chiralcel OJ column (250 × 4.6 mm, n-hexane/i-PrOH ) 94/6,
1 mL/min) monitored at 235 nm. Both racemic and optically
enriched 2 were prepared according to literature procedures.3,8
Acetic Acid (1S*,8a S*)-(()-8a -Meth yl-6-oxo-1,2,3,4,6,7,
8,8a -octa h yd r on a p h th a len -1-yl Ester (3).17 To an ice-cooled
solution of the racemic hydroxyenone 2 (760 mg, 4.22 mmol) in
6 mL of pyridine was slowly added 0.5 mL of Ac2O (5.29 mmol).
The reaction was kept at room temperature and stirred over-
night. The progress of the reaction was monitored by TLC
(hexane/EtOAc ) 4/6). After the reaction was complete (∼12 h),
a few drops of H2O were added to quench the reaction. The
mixture was stirred for another 30 min, and pyridine was
Alca la se-Ca ta lyzed Hyd r olysis of (1S,8a S)-En r ich ed Bu -
tan oic Acid 8a-Meth yl-6-oxo-1,2,3,4,6,7,8,8a-octah ydr on aph -
th a len -1-yl Ester (4) (Gr a m Sca le). To a solution of (1S,8aS)-
enriched butanoate-4 (1.00 g, 58% ee) in 12 mL of DMF was
added 66 mL of phosphate buffer (0.3 M, pH 7.0) and 2 mL of
alcalase. The mixture was placed in a shaker at 37 °C for 48 h.
After enzymatic hydrolysis, both the hydroxyenone product 2
and the remaining ester 4 were extracted from the mixture with
EtOAc (200 mL ×3). The EtOAc extracts were combined and
concentrated. The residual oil was partitioned between hexane/
H2O. The remaining ester 4 goes to the hexane layer, while the
hydroxyenone product 2 stays in aqueous phase. The aqueous
phase was extracted with EtOAc (x3) and the desired product
(16) Franssen, M. C. R.; J ongejan, H.; Kooijman, H.; Spek, A. L.;
Bell, R. P. L.; Wijnberg, J . B. P. A.; de Groot, A. Tetrahedron:
Asymmetry 1999, 10, 2729-2738.
(17) Harada, N.; Kohori, J .; Uda, H.; Nakanishi, K.; Takeda, R. J .
Am. Chem. Soc. 1985, 107, 423-428.